Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder

NCT02362529 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT02362529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02362529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder
Lead sponsor
Centre for Addiction and Mental Health
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2015
Completion date
April 30, 2019
Enrollment
115 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder